Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

BioNJ Announces Lineup for BioPartnering Conference


TRENTON, N.J., April 25, 2024 /PRNewswire/ -- BioNJ is pleased to host its 14th Annual BioPartnering Conference on Tuesday, May 14, at the Liberty Science Center in Jersey City. Sponsored by J.P. Morgan, Johnson & Johnson and Morgan Lewis and hosted by Jersey City Economic Development Corp., the Conference will bring together life sciences executives, investors, strategics, academic collaborators and business development professionals for 1-1 partnering, Industry Connections (office hours with large biopharma companies), exhibits, company pitch presentations, plenary sessions and lots of networking -- including a closing networking reception. 

The action-packed schedule is designed to create meaningful opportunities, grow the ecosystem and bolster medical innovation. Timely plenary sessions will include:

And, featuring thought leaders, such as:

In addition, attendees can schedule 10-minute appointments at the Industry Connections Desk offering one-on-one time with BD professionals from large biopharma companies, such as Ferring Pharmaceuticals, Johnson & Johnson, Merck & Co., Pfizer, Sanofi and Teva Pharmaceuticals.

"The BioPartnering Conference is the ideal chance to discover innovative companies for investment portfolios," BioNJ President and CEO Debbie Hart noted. "We have more than 90 companies from the life sciences, biotech, healthcare and digital health sectors presenting new innovations and technologies. With the One-on-One Partnering System open, attendees can begin scheduling meetings to explore collaboration opportunities."

Emerging companies that will be presenting include:

Early stage start-up pitches include:

Conference attendees will have the opportunity to meet with a wide variety of exhibitors showcasing valuable resources, products and services available to the BioNJ community, including:

"We look forward to welcoming BioNJ's preeminent 2024 BioPartnering Conference to the Liberty Science Center and introducing attendees to SciTech Scity, the 30-acre innovation campus we are now building that will focus on biomedical science, home healthcare, planet care and artificial intelligence," said Paul Hoffman, President and CEO, Liberty Science Center and SciTech Scity. 

Register and find additional information at BioNJ.org/BioPartnering. Registration is $425 for BioNJ Members and $525 for Future BioNJ Members. Last year's BioPartnering Conference brought together nearly 600 attendees from 16 states and 16 countries as well as the District of Columbia. 

Media Contact
Randi Bromberg
Sr. Vice President, Communications and Marketing
O) 609-890-3185
C) 609-955-1067
[email protected]

SOURCE BioNJ


These press releases may also interest you

at 12:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest real-world patient cohort review...

at 11:30
The Aesthetic Foundation, formerly known as the Aesthetic Surgery Education and Research Foundation (ASERF), proudly announces the election of Dr. Onelio Garcia Jr. "Oni", as its new President. Dr. Garcia's appointment heralds an exciting chapter for...

at 11:03
The Aesthetic Society proudly announces the appointment of Dr. Kiya Movassaghi, a board-certified plastic surgeon from Eugene, OR, as the President of The Aesthetic Society. Dr. Movassaghi's leadership will focus on strategically fortifying The...

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:00
Today, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations; the Honourable Patty Hajdu, Minister of Indigenous Services and Minister responsible for FedNor; the Honourable Dan Vandal, Minister of Northern Affairs; and the...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...



News published on and distributed by: